3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Leiomyoma
4
Ovarian Neoplasms
3
Endometrial Neoplasms
3
Uterine Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Dysplasia
1
Precancerous Conditions
1
Myofibroma
1
Metrorrhagia
1
Menstruation Disturbances
1
Menorrhagia
1
Hysterectomy
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Endometriosis
1
Endometrial Hyperplasia
1
Disease
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Endometrioid
1
Carcinoma, Adenosquamous
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
Peripheral Blood Stem Cell Transplantation
9
Cyclophosphamide
9
Biopsy
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Tacrolimus
5
Mycophenolic Acid
5
Epoetin Alfa
5
Colposcopy
5
Celecoxib
5
Busulfan
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Methotrexate
4
Melphalan
4
Cyclosporine
4
Cetuximab
4
Antilymphocyte Serum
4
Polymerase Chain Reaction
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Gene Expression Profiling
3
Etoposide
3
Eflornithine
3
Darbepoetin alfa
3
Carboplatin
3
Aspirin
3
fludarabine
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precancerous Conditions
×
Hysterectomy
×
Clear all
NCT07120945
2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA
Recruiting
70 enrolled